Valuation Nipro Corporation OTC Markets

Stocks

Market Closed - OTC Markets 21:07:10 04/03/2026 +03			5-day change	1st Jan Change
9.960 ^USD	+2.79%		-.--%	+21.02%

07-30	Nipro Corporation Receives Fda 510(K) Clearance for Elisio-Hx Dialyzer and Introduces Hds to the United States	CI
07-29	Vat Holding AG agreed to acquire 100% stake in Atonarp Inc. from Nipro Corporation for CHF 110 million.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	167,011	166,195	199,874	221,565	253,125	262,201	-	-
Change	-	-0.49%	20.26%	10.85%	14.24%	3.59%	-	-
Enterprise Value (EV) ¹	636,521	672,257	730,303	745,971	796,341	771,327	751,558	726,223
Change	-	5.61%	8.63%	2.15%	6.75%	-3.14%	-2.56%	-3.37%
P/E	12.4x	36.3x	18x	43.3x	18.7x	17.2x	13.3x	9.88x
PBR	0.9x	0.81x	0.86x	0.88x	0.92x	0.93x	0.87x	0.82x
PEG	-	-0.6x	0x	-0.8x	0x	1.4x	0.4x	0.3x
Capitalization / Revenue	0.34x	0.3x	0.34x	0.34x	0.38x	0.37x	0.36x	0.34x
EV / Revenue	1.29x	1.23x	1.24x	1.16x	1.21x	1.1x	1.03x	0.95x
EV / EBITDA	9.09x	10.1x	8.99x	8.09x	7.86x	7.34x	6.58x	5.85x
EV / EBIT	26.7x	37.9x	32.7x	28x	21.2x	19.3x	16.3x	13.9x
EV / FCF	-62.3x	-11x	-24x	-218x	-48.4x	37.2x	44.1x	31.2x
FCF Yield	-1.61%	-9.12%	-4.17%	-0.46%	-2.06%	2.69%	2.27%	3.21%
Dividend per Share ²	27	22	25	25	29	36.25	45.5	56.25
Rate of return	2.64%	2.16%	2.04%	1.84%	1.87%	2.27%	2.85%	3.53%
EPS ²	82.5	28.05	68.12	31.36	82.8	92.77	120.4	161.5
Distribution rate	32.7%	78.4%	36.7%	79.7%	35%	39.1%	37.8%	34.8%
Net sales ¹	494,789	545,199	586,785	644,586	660,538	700,654	728,900	761,413
EBITDA ¹	70,046	66,472	81,207	92,246	101,361	105,023	114,303	124,083
EBIT ¹	23,882	17,729	22,335	26,598	37,624	39,981	46,073	52,136
Net income ¹	13,455	4,574	11,109	5,113	13,504	15,393	19,953	24,140
Net Debt ¹	469,510	506,062	530,429	524,406	543,216	509,126	489,357	464,022
Reference price ²	1,024.00	1,019.00	1,225.50	1,358.50	1,552.00	1,595.00	1,595.00	1,595.00
Nbr of stocks (in thousands)	163,097	163,097	163,096	163,096	163,096	164,389	-	-
Announcement Date	5/11/22 A	5/11/23 A	5/10/24 A	5/12/25 A	5/12/26 A	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	31.91x	4.3x	16.65x	2.31%	193B
MEDTRONIC PLC	20.68x	3.58x	12.58x	3.26%	117B
CENCORA, INC.	17.18x	0.2x	12.43x	0.76%	59.89B
HOYA CORPORATION	32.51x	8.12x	20.71x	1.22%	56.01B
BECTON, DICKINSON AND COMPANY	35.34x	3.41x	11.7x	2.14%	49.96B
DEXCOM, INC.	35.98x	6.33x	19.87x	-.--%	33.87B
MEDLINE INC.	46.51x	1.32x	12.08x	0.16%	31.36B
TERUMO CORPORATION	20.88x	3.19x	11.7x	1.4%	24.77B
WEST PHARMACEUTICAL SERVICES, INC.	40.75x	7.14x	25.62x	0.26%	24.59B
Average	31.30x	4.18x	15.93x	1.28%	65.53B
Weighted average by Cap.	29.45x	4.06x	15.49x	1.85%